Vijoice
alpelisib
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
Sotyktu
deucravacitinib
Psoriasis
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanAuthorised
Piqray
alpelisib
Breast Neoplasms
Date of authorisation:
Revision: 10
Last updated:
MedicineHumanAuthorised
EMEA-002016-PIP03-19-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0412/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Granules
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002016-PIP04-20 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0122/2021
Route(s) of administration: All routes of administration
Pharmaceutical form(s):
All pharmaceutical forms
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002016-PIP02-16 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0079/2017
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman